Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-6 inhibition in the management of non-infectious uveitis and beyond.
Karkhur S, Hasanreisoglu M, Vigil E, Halim MS, Hassan M, Plaza C, Nguyen NV, Afridi R, Tran AT, Do DV, Sepah YJ, Nguyen QD. Karkhur S, et al. Among authors: afridi r. J Ophthalmic Inflamm Infect. 2019 Sep 16;9(1):17. doi: 10.1186/s12348-019-0182-y. J Ophthalmic Inflamm Infect. 2019. PMID: 31523783 Free PMC article. Review.
Blue light versus green light fundus autofluorescence in normal subjects and in patients with retinochoroidopathy secondary to retinal and uveitic diseases.
Bittencourt MG, Hassan M, Halim MS, Afridi R, Nguyen NV, Plaza C, Tran ANT, Ahmed MI, Nguyen QD, Sepah YJ. Bittencourt MG, et al. Among authors: afridi r. J Ophthalmic Inflamm Infect. 2019 Jan 8;9(1):1. doi: 10.1186/s12348-018-0167-2. J Ophthalmic Inflamm Infect. 2019. PMID: 30617430 Free PMC article.
Effect of vitreomacular adhesion on the treatment outcomes in the STOP-Uveitis clinical trial for non-infectious uveitis.
Hassan M, Nguyen NV, Halim MS, Afridi R, Sadiq MA, Karkhur S, Vigil E, Karabekirogullari S, Nguyen QD, Do DV, Sepah YJ; STOP-Uveitis Investigators. Hassan M, et al. Among authors: afridi r. J Ophthalmic Inflamm Infect. 2019 Jul 19;9(1):12. doi: 10.1186/s12348-019-0179-6. J Ophthalmic Inflamm Infect. 2019. PMID: 31325001 Free PMC article.
Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis.
Sepah YJ, Sadiq MA, Chu DS, Dacey M, Gallemore R, Dayani P, Hanout M, Hassan M, Afridi R, Agarwal A, Halim MS, Do DV, Nguyen QD. Sepah YJ, et al. Among authors: afridi r. Am J Ophthalmol. 2017 Nov;183:71-80. doi: 10.1016/j.ajo.2017.08.019. Epub 2017 Sep 5. Am J Ophthalmol. 2017. PMID: 28887113 Clinical Trial.
Pharmacological agents in development for diabetic macular edema.
Sadiq MA, Halim MS, Hassan M, Onghanseng N, Karaca I, Agarwal A, Afridi R, Sepah YJ, Do DV, Nguyen QD. Sadiq MA, et al. Among authors: afridi r. Int J Retina Vitreous. 2020 Jul 8;6:29. doi: 10.1186/s40942-020-00234-z. eCollection 2020. Int J Retina Vitreous. 2020. PMID: 32670612 Free article. Retracted. Review.
Differences in the characteristics of subjects achieving complete, partial, or no resolution of macular edema in the READ-3 study.
Halim MS, Afridi R, Hasanreisoglu M, Hassan M, Ibrahim-Ahmed M, Do DV, Sepah YJ; READ-3 Investigators. Halim MS, et al. Among authors: afridi r. Graefes Arch Clin Exp Ophthalmol. 2021 Oct;259(10):2941-2948. doi: 10.1007/s00417-021-05148-6. Epub 2021 Apr 1. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 33792788 Free PMC article. Clinical Trial.
65 results